Medicine makers are increasingly partnering with medical research centers and institutes to develop more effective peptide medicines. This, in turn, is projected to make a positively impact on the growth of the global peptide based gastrointestinal disorders therapeutics market in
source https://www.openpr.com/news/2267470/linaclotide-to-hold-2-3rd-of-global-peptide-based